Napo pharmaceuticals supports groundbreaking study on quality of life for cancer patients and survivors

San francisco, ca / accesswire / september 26, 2023 / in an effort to shed light on the diverse and profound challenges faced by individuals living with a diagnosis or a history of cancer, napo pharmaceuticals (napo), a jaguar health, inc. (nasdaq:jagx) family company, today announced they were proud to provide fiscal support for "more than a diagnosis: a quality of life survey for individuals with a diagnosis or history of cancer." the online, anonymous survey was an initiative of advocates for collaborative education (ace).
JAGX Ratings Summary
JAGX Quant Ranking